Trump Vows to Cut Prescription Drug Prices by Up to 80% with Executive Order

Strategic Insights -

The US President has vowed to use his executive powers to reduce prescription drug prices, aiming to bring them in line with other countries. Donald Trump has announced plans to sign an order on Monday that will supposedly reduce prices by "30% to 80%". This move is likely to impact pharmaceutical companies, with shares already experiencing a sell-off in response to the news. Trump has stated that his proposal would implement a "most favoured nation" policy, which would see the US pay the same price for prescription drugs as the country that pays the lowest price worldwide.

Key Takeaways:

  • Trump plans to sign an executive order reducing prescription drug prices by "30% to 80%" through a "most favoured nation" policy.
  • The policy would see the US pay the same price for prescription drugs as the country that pays the lowest price worldwide.
  • Pharmaceutical stocks experienced a sell-off in response to the news, with shares in companies such as AstraZeneca, GSK, and Novo Nordisk dropping significantly.
  • Trump's proposal is a revised attempt at addressing high drug costs, after his first administration's efforts were struck down in federal court.
  • The American government already negotiates prices for certain medicines used in Medicare, a federal health insurance programme.

Statistics:

  • Trump estimates that prescription drug prices could be reduced by 30% to 80%.
  • Pharmaceutical stocks dropped by up to 8.9% in response to the news, with shares in companies such as BeiGene and Innovent Biologics falling 8.9% and 7%, respectively.
  • The US spends significantly more on prescription drugs than other countries, with prices up to 3 times higher in some cases.
  • Medicare covers 66 million Americans, mostly aged 65 or over.

Sources:

  • Donald Trump, Truth Social

- https://truthsocial.com/

  • Bloomberg - Pharmaceutical stocks fall sharply amid Trump's price-cut pledge

- https://www.bloomberg.com/news/articles/2024-02-26/pharmaceutical-stocks-fall-sharply-amid-trump-s-price-cut-pledge